Towana Looney

Towana Looney

patient United States

Towana Looney is known for being the first recipient of a pig kidney transplant, and she provided support and advice to Tim Andrews as he prepared for his own pioneering surgery.

Born on Nov 25, 1969 (55 years old)

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
0
Power
0$
Sentiment
0.00
Countries Mentioned

No country-level mention data available.

Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Italy Italy: Towana Looney was the first to receive a genetically modified pig kidney and lived with it for four months and nine days. 9

Corriere della Sera: Xenotrapianto di rene: dopo quattro mesi, l'organo di maiale geneticamente modificato è stato asportato

Vietnam Vietnam: Towana Looney lived with a pig kidney for a record 130 days before it had to be removed due to her body starting to reject it. 7

VnExpress – leading Vietnamese online newspaper, est. 2001: Ca ghép thận lợn cho người thất bại sau 130 ngày

India India: Towana Looney lived with a genetically engineered pig's kidney for 130 days before experiencing acute organ rejection. 6

The Times of India: Pig kidney removed from US woman after 130 days due to organ rejection

United States United States: Towana Looney, a pig kidney transplant recipient, gets a morning check-up with Dr. Jeffrey Stern at NYU Langone Health. 7

Fox News: Alabama woman has pig kidney removed after a record 130 days

Monaco Monaco: Towana Looney, a patient from Alabama, had a genetically modified pig kidney transplanted and later removed after four months of functioning. 7

Monaco-Matin – newspaper covering the Principality of Monaco: Retrait d'un rein de porc d'une patiente américaine après quatre mois de fonctionnement, un record

Italy Italy: Towana Looney is the first person in the United States to live for three months after receiving a pig kidney transplant. 9

Corriere della Sera: Xenotrapianto di fegato: l'organo di maiale geneticamente modificato funziona 10 giorni in paziente in morte cerebrale